Carbon markets facing uncertain new year after Durban

What next for carbon markets?

COP17 - Climate talks in Durban - December 6 2011
Attendees at the Durban climate change talks included (l to r) Jacob Zuma, Maite Nkoana-Mashabane and Richard Kinley

Last year may have seemed like the year carbon trading lost its allure. In August, JP Morgan sold emissions offset developer ClimateCare back to itself and in October the bank’s managing director for environmental markets, Odin Knudsen, left his position, citing the impact on the business of the failure to create a US federal carbon trading scheme. More recently, Société Générale sold its 50% interest in carbon trading company Orbeo back to partner Rhodia’s parent company, Solvay.

In the meantime

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Register

Want to know what’s included in our free membership? Click here

This address will be used to create your account

Chartis Energy50 2023

The latest iteration of Chartis' Energy50 2023 ranking and report considers the key issues in today’s energy space, and assesses the vendors operating within it

2021 brings big changes to the carbon market landscape

ZE PowerGroup Inc. explores how newly launched emissions trading systems, recently established task forces, upcoming initiatives and the new US President, Joe Biden, and his administration can further the drive towards tackling the climate crisis

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here